2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Ezra A. Amsterdam(University of California, Davis), Susan J. Zieman(National Institute on Aging), Donald E. Casey, Glenn N. Levine(American College of Cardiology), Hani Jneid(The University of Texas MD Anderson Cancer Center), Marc S. Sabatine(Brigham and Women's Hospital), Rosemary F. Kelly, Ralph G. Brindis, Philip R. Liebson(Northwestern University), Théodore G. Ganiats(University of California San Diego), Allan S. Jaffe(Mayo Clinic in Arizona), David R. Holmes(Mayo Clinic in Florida), Richard W. Smalling(Memorial Hermann), Michael C. Kontos(Virginia Commonwealth University), Debabrata Mukherjee(Texas Tech University), Eric D. Peterson, Nanette K. Wenger(American Heart Association)
Cited by 3,613
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k